|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/71 | (2006.01) |
| C07K 16/22 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K 16/46 | (2006.01) | ||
| C07K 19/00 | (2006.01) |
| (11) | Number of the document | 3105246 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15717097.8 |
| Date of filing the European patent application | 2015-02-10 | |
| (97) | Date of publication of the European application | 2016-12-21 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-31 |
| (46) | Date of publication of the claims translation | 2021-08-25 |
| (86) | Number | PCT/EP2015/052781 |
| Date | 2015-02-10 |
| (87) | Number | WO 2015/118175 |
| Date | 2015-08-13 |
| (30) | Number | Date | Country code |
| 201461938048 P | 2014-02-10 | US |
| (72) |
LO, Kin-Ming, US
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Tikslinis TGF beta slopinimas |
| TARGETED TGF BETA INHIBITION |
| Payment date | Validity (years) | Amount | |
| 2024-12-20 | 11 | 289.00 EUR |
| 2026-02-10 |